SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-308673
Filing Date
2021-10-27
Accepted
2021-10-27 07:16:03
Documents
12
Period of Report
2021-10-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d53143d8k.htm   iXBRL 8-K 25457
  Complete submission text file 0001193125-21-308673.txt   148739

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hcwb-20211027.xsd EX-101.SCH 2905
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hcwb-20211027_lab.xml EX-101.LAB 18124
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hcwb-20211027_pre.xml EX-101.PRE 11414
5 EXTRACTED XBRL INSTANCE DOCUMENT d53143d8k_htm.xml XML 3321
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 211350681
SIC: 2834 Pharmaceutical Preparations